Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Dermatology|August 12, 2009
Etanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infectionS E Behnam, R Hindiyeh, D J Fife, et al.
The American Journal of Dermatopathology|December 1, 1993
Localized bullous scabies. Uncommon presentation of scabiesS Said, S Jay, J Kang, et al.
Lymphokine Research|January 1, 1990
Identification of TNF-LT blocking factor(s) in the serum and ultrafiltrates of human cancer patientsT Gatanaga, R Lentz, I Masunaka, et al.
Lymphokine and Cytokine Research|April 1, 1991
A simple nonisotopic in vitro bioassay for LT and TNF employing sodium fluoride-treated L-929 target cells that detects picogram quantities of LT and TNF and is as sensitive as TNF assays done with ELISA methodologyE W Jeffes, K Schmitz, R Yamamoto, et al.
Journal of Clinical Immunology|July 1, 1987
Purified native and recombinant human alpha lymphotoxin [tumor necrosis factor (TNF)-beta] induces inflammatory reactions in normal skinB J Averbook, R S Yamamoto, T R Ulich, et al.
Journal of the American Academy of Dermatology|June 26, 2001
Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue lightE W Jeffes, J L McCullough, G D Weinstein, et al.
International Immunopharmacology|May 19, 2001
Dexamethasone increases the expression of membrane macrophage colony stimulating factor from retrovirally transduced tumor cells expressing macrophage colony stimulating factorQ Dan, H Trinh, C C Williams, et al.
Arthritis and Rheumatism|September 1, 1989
The presence of antibodies to lymphotoxin and tumor necrosis factor in normal serumE W Jeffes, E K Ininns, K L Schmitz, et al.
The Journal of Clinical Investigation|July 1, 1989
Production of lymphotoxin by isolated human tonsillar B lymphocytes and B lymphocyte cell linesS S Sung, L K Jung, J A Walters, et al.
Lymphokine and Cytokine Research|April 1, 1991
Therapy of recurrent high-grade gliomas with surgery, autologous mitogen-activated IL-2-stimulated (MAK) killer lymphocytes, and rIL-2: II. Correlation of survival with MAK cell tumor necrosis factor production in vitroE W Jeffes, Y B Beamer, S Jacques, et al.
Pageof 4